IGF1R and prostate cancer: Isebaert et al. demonstrated that the IGF-1R TKI NVP-AEW541 enhances radiosensitivity in phosphatase and tensin homolog (PTEN) wild-type but not PTEN-deficient human prostate cancer cells [77].